Pharmaceutical Preparations: what changed in each company's latest annual report

Of 24 Pharmaceutical Preparations companies with comparable revenue, 20 grew it and 4 saw it fall in their latest annual report. The median change was up 6.1%.

Biggest revenue gains

• Madrigal Pharmaceuticals, Inc.Revenue up 432.1%
• BridgeBio Pharma, Inc.Revenue up 126.3%
• Insmed IncRevenue up 66.7%
• Alnylam Pharmaceuticals, Inc.Revenue up 65.2%
• Eli Lilly And CompanyRevenue up 44.7%

Biggest revenue declines

• Roivant Sciences Ltd.Revenue down 71.6%
• Viatris Inc.Revenue down 3%
• Pfizer IncRevenue down 1.6%
• Bristol-Myers Squibb CompanyRevenue down 0.2%

All 25 companies

• Eli Lilly And CompanyCash and cash equivalents up 122.4%
• Johnson & JohnsonNet income up 90.6%
• AbbVie Inc.Revenue up 8.6%
• Merck & Co., Inc.Long-term debt up 35.7%
• Abbott LaboratoriesNet income down 51.3%
• Pfizer IncCash and cash equivalents up 9.5%
• Vertex Pharmaceuticals Inc / MaTotal liabilities up 13.9%
• Bristol-Myers Squibb CompanyShareholders' equity up 13.1%
• Regeneron Pharmaceuticals, Inc.Cash and cash equivalents up 25.3%
• Teva Pharmaceutical Industries LimitedShareholders' equity up 47.2%
• Beone Medicines Ltd.Long-term debt up 477.8%
• Royalty Pharma plcCash and cash equivalents down 33.4%
• Zoetis Inc.Long-term debt up 73.2%
• Alnylam Pharmaceuticals, Inc.Shareholders' equity up 1076.3%
• Roivant Sciences Ltd.Revenue down 71.6%
• United Therapeutics CorporationTotal liabilities down 14.8%
• Viatris Inc.Cash and cash equivalents up 80%
• Insmed IncShareholders' equity up 158.9%
• Jazz Pharmaceuticals plcCash and cash equivalents down 42.3%
• BridgeBio Pharma, Inc.Revenue up 126.3%
• Summit Therapeutics Inc.Cash and cash equivalents up 114.8%
• Corcept Therapeutics IncNet income down 29.4%
• Elanco Animal Health IncorporatedCash and cash equivalents up 16.5%
• Biomarin Pharmaceutical IncCash and cash equivalents up 39.1%
• Madrigal Pharmaceuticals, Inc.Revenue up 432.1%